Esperion Therapeutics Balance Sheet (2012-2026) | ESPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	219.19M	103.67M	208.89M	150.36M	122.94M	159.40M	124.78M	144.91M	138.47M	114.83M	82.25M	226.61M	189.30M	144.72M	144.76M	114.63M	86.06M	92.45M	167.85M	156.16M
Short-term Investments (Quarter)			50.44M	68.14M	62.91M	29.94M	42.09M	17.43M
Cash & Current Investments (Quarter)	219.19M	103.67M	259.33M	218.50M	185.84M	189.34M	166.86M	162.34M	138.47M	114.83M	82.25M	226.61M	189.30M	144.72M	144.76M	114.63M	86.06M	92.45M	167.85M	156.16M
Receivables - Net (Quarter)	21.85M	21.71M	22.93M	25.12M	27.84M	31.49M	33.73M	36.41M	40.80M	42.62M	48.49M	54.61M	60.36M	67.82M	80.14M	81.29M	107.75M	118.98M	140.19M	132.35M
Receivables - Other (Quarter)
Receivables (Quarter)	21.85M	21.71M	22.93M	25.12M	27.84M	31.49M	33.73M	36.41M	40.80M	42.62M	48.49M	54.61M	60.36M	67.82M	80.14M	81.29M	107.75M	118.98M	140.19M	132.35M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	23.71M	33.97M	34.39M	35.65M	29.23M	29.55M	35.20M	39.35M	45.68M	51.44M	65.62M	73.09M	84.47M	80.10M	94.49M	99.32M	114.47M	108.54M	105.12M	104.21M
Prepaid Assets (Quarter)	9.77M	0.99M	11.17M	0.70M	0.37M	9.21M	9.87M	6.92M	4.32M	6.29M	0.19M		0.35M	0.50M	4.16M	4.82M	4.17M	4.41M	4.50M	5.79M
Current Assets (Quarter)	275.17M	170.67M	328.97M	290.82M	252.48M	261.79M	246.68M	250.60M	232.12M	218.23M	201.06M	365.61M	345.11M	307.56M	338.00M	318.78M	342.60M	360.46M	462.57M	459.46M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.97M	0.82M	0.66M	0.51M	0.36M	0.26M	0.16M	0.08M	0.03M	0.01M		0.27M	0.31M	0.28M	0.25M	0.23M	0.20M	0.17M	0.34M	0.31M
Long-Term Investments (Quarter)
Intangibles (Quarter)			0.06M				0.06M
Goodwill & Intangibles (Quarter)	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)		50.00M	50.00M	50.00M	50.00M	50.00M
Non-Current Assets (Quarter)	5.29M	54.59M	52.62M	52.03M	51.50M	51.04M	1.26M	1.21M	2.50M	3.08M	4.73M	7.45M	7.21M	6.56M	5.82M	5.25M	4.49M	3.56M	3.32M	3.07M
Assets (Quarter)	280.46M	225.26M	381.59M	342.85M	303.98M	312.83M	247.94M	251.82M	234.63M	221.31M	205.80M	373.06M	352.32M	314.11M	343.82M	324.03M	347.08M	364.02M	465.89M	462.53M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	29.35M	20.75M	17.56M	26.83M	12.83M	18.58M	23.04M	17.07M	24.56M	26.21M	31.72M	28.43M	47.67M	34.86M	51.65M	71.99M	74.70M	77.51M	65.07M	68.41M
Notes Payables (Quarter)															54.58M	54.67M	54.77M	54.86M
Payables (Quarter)	29.35M	20.75M	17.56M	26.83M	12.83M	18.58M	23.04M	17.07M	24.56M	26.21M	31.72M	28.43M	47.67M	34.86M	106.22M	126.66M	129.47M	132.38M	65.07M	68.41M
Accumulated Expenses (Quarter)	2.87M	3.75M	7.01M	6.33M	7.54M	35.40M	5.43M	4.62M	12.85M	3.45M	25.00M	23.14M	3.42M	3.55M	19.59M	16.62M	8.37M	18.64M	4.12M	2.68M
Other Accumulated Expenses (Quarter)			30.41M				13.20M				25.00M
Short term Debt (Quarter)
Current Leases (Quarter)	2.35M	2.40M	1.39M	1.22M	0.96M	0.69M	0.38M	0.30M	0.69M	0.92M	1.55M	2.54M	2.68M	2.74M	2.74M	2.82M	2.74M	2.38M	2.10M	1.70M
Current Deferred Revenue (Quarter)	3.93M	3.07M	5.68M	3.79M	5.03M	4.04M	3.51M	12.16M	15.63M	19.72M	25.40M	29.35M	20.67M	15.08M	8.52M	4.54M	22.31M	30.68M	34.48M	43.53M
Total Current Liabilities (Quarter)	82.64M	78.48M	73.35M	79.08M	82.28M	82.34M	92.31M	95.49M	107.17M	137.71M	156.22M	164.51M	175.34M	165.87M	246.23M	270.97M	298.80M	359.03M	300.81M	300.36M
Non-Current Liabilities
Non-Current Debt (Quarter)															140.97M	141.45M	146.45M	151.65M	152.22M	152.67M
Convertible Debt (Quarter)	272.10M	272.51M	258.28M	258.68M	259.08M	259.49M	259.90M	260.32M	260.74M	261.17M	261.60M	262.03M	262.48M	262.92M	96.75M	96.87M	97.00M	97.13M	97.26M	97.39M
Non-Current Deffered Revenue (Quarter)	1.06M	0.84M	0.63M	0.42M	0.21M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	1.92M	1.31M	0.52M	0.26M	0.14M	0.05M	0.67M	0.78M	1.70M	2.05M	3.02M	4.42M	3.98M	3.30M	5.31M	1.97M	1.31M	0.77M	0.65M	0.86M
Other Non-Current Liabilities (Quarter)	1.29M	233.52M	245.74M	253.44M	253.98M	265.05M	218.84M	224.90M	236.99M	230.39M	239.95M	236.40M					7.44M	7.44M	8.74M	8.74M
Total Non-Current Liabilities (Quarter)	583.48M	354.44M	332.79M	338.45M	341.70M	341.88M	352.87M	356.58M	369.61M	400.92M	420.84M	430.96M	696.54M	684.32M	732.54M		773.16M	807.95M	759.11M	761.72M
Total Liabilities (Quarter)	584.77M	587.96M	578.53M	591.89M	595.68M	606.93M	571.72M	581.48M	606.60M	631.31M	660.79M	667.36M	696.54M	684.32M	732.54M	750.24M	780.59M	815.38M	767.85M	770.46M
Shareholder's Equity
Total Debt (Quarter)															140.97M	141.45M	146.45M	151.65M	152.22M	152.67M
Common Equity (Quarter)	-304.31M	-362.70M	-196.94M	-249.04M	-291.70M	-294.10M	-323.78M	-329.66M	-371.98M	-410.00M	-454.99M	-294.30M	-344.22M	-370.21M	-388.72M	-426.21M	-433.51M	-451.36M	-301.96M	-307.93M
Shareholder's Equity (Quarter)	-304.31M	-362.70M	-196.94M	-249.04M	-291.70M	-294.10M	-323.78M	-329.66M	-371.98M	-410.00M	-454.99M	-294.30M	-344.22M	-370.21M	-388.72M	-426.21M	-433.51M	-451.36M	-301.96M	-307.93M
Liabilities and Shareholders Equity (Quarter)	280.46M	225.26M	381.59M	342.85M	303.98M	312.83M	247.94M	251.82M	234.63M	221.31M	205.80M	373.06M	352.32M	314.11M	343.82M	324.03M	347.08M	364.02M	465.89M	462.53M
Treasury Shares (Quarter)	1.99M	1.99M	1.99M	1.99M	1.99M	1.99M	1.99M	1.99M	3.04M	1.99M	1.99M	6.04M	1.99M	4.97M	1.99M	1.99M	1.99M	7.28M	7.11M	1.99M
Retained Earnings (Quarter)	-971.87M	-1041.26M	-0.03M	-1163.11M	-0.30M	-1284.55M	-0.00M	-0.00M		-1492.94M	-1549.28M	-1488.26M	-1550.19M	-1579.71M		-1641.48M	-1654.21M	-1685.54M	-1623.71M	-1648.91M

Research Tools

Esperion Therapeutics Balance Sheet (2012-2026) | ESPR

Create an account

Sign In

Reset Password